{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-086674","form_type":"8-K","ticker":"LIMN","cik":"0001971387","company_name":"Liminatus Pharma, Inc.","filed_at":"2026-07-24T20:51:25+00:00","discovered_at":"2026-07-24T20:52:00.384507+00:00","generated_at":"2026-07-24T20:52:06.136269+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Liminatus Pharma receives Nasdaq notice of non-compliance with Bid Price Rule; Panel to decide on continued listing","bullets":["Received Nasdaq notice on July 20, 2026 that it has not regained compliance with $1 minimum bid price rule and is not eligible for second 180-day extension.","Nasdaq Hearings Panel will consider this deficiency in decision on continued listing; company must submit written view by July 27, 2026.","Company filed definitive proxy for August 3, 2026 annual meeting to authorize reverse stock split, a potential cure for bid price deficiency.","No assurance that Panel will grant additional time or that company will regain compliance with Nasdaq listing rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-086674","json":"https://secwatch.observer/filing/0001104659-26-086674.json","markdown":"https://secwatch.observer/filing/0001104659-26-086674.md","text":"https://secwatch.observer/filing/0001104659-26-086674.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926086674/0001104659-26-086674-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926086674/tm2621298d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-24T20:52:06.136269+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}